Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

224 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Role of PD-L1 on Langerhans Cells in the Regulation of Psoriasis.
Tanaka R, Ichimura Y, Kubota N, Konishi R, Nakamura Y, Mizuno S, Takahashi S, Fujimoto M, Nomura T, Okiyama N. Tanaka R, et al. Among authors: ichimura y. J Invest Dermatol. 2022 Dec;142(12):3167-3174.e9. doi: 10.1016/j.jid.2022.06.006. Epub 2022 Jul 6. J Invest Dermatol. 2022. PMID: 35803322 Free article.
Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins.
Fujimoto M, Hamaguchi Y, Kaji K, Matsushita T, Ichimura Y, Kodera M, Ishiguro N, Ueda-Hayakawa I, Asano Y, Ogawa F, Fujikawa K, Miyagi T, Mabuchi E, Hirose K, Akimoto N, Hatta N, Tsutsui K, Higashi A, Igarashi A, Seishima M, Hasegawa M, Takehara K. Fujimoto M, et al. Among authors: ichimura y. Arthritis Rheum. 2012 Feb;64(2):513-22. doi: 10.1002/art.33403. Arthritis Rheum. 2012. PMID: 21987216 Free article.
Augmented interferon I signaling in a patient with COVID toes.
Komura K, Ichimura Y, Okiyama N, Watanabe K, Muramoto H, Matsushita T. Komura K, et al. Among authors: ichimura y. J Dermatol. 2021 May;48(5):e242-e243. doi: 10.1111/1346-8138.15864. Epub 2021 Mar 21. J Dermatol. 2021. PMID: 33745200 Free PMC article. No abstract available.
Immune response to dermatomyositis-specific autoantigen, transcriptional intermediary factor 1γ can result in experimental myositis.
Okiyama N, Ichimura Y, Shobo M, Tanaka R, Kubota N, Saito A, Ishitsuka Y, Watanabe R, Fujisawa Y, Nakamura Y, Murakami A, Kayama H, Takeda K, Fujimoto M. Okiyama N, et al. Among authors: ichimura y. Ann Rheum Dis. 2021 Sep;80(9):1201-1208. doi: 10.1136/annrheumdis-2020-218661. Epub 2021 Apr 2. Ann Rheum Dis. 2021. PMID: 33811031
A case of anti-PL-7 antibody-positive anti-synthetase syndrome with dermatomyositis-associated erythema induced sclerodermatous changes.
Fukuzono M, Sasaki K, Ichimura Y, Inoue S, Iwasaki R, Imai H, Saito A, Kubota N, Tanaka R, Nakamura Y, Fujisawa Y, Fujimoto M, Nomura T, Okiyama N. Fukuzono M, et al. Among authors: ichimura y. Rheumatology (Oxford). 2021 Oct 2;60(10):e362-e364. doi: 10.1093/rheumatology/keab370. Rheumatology (Oxford). 2021. PMID: 33892494 No abstract available.
Anti-nuclear matrix protein 2 antibody-positive inflammatory myopathies represent extensive myositis without dermatomyositis-specific rash.
Ichimura Y, Konishi R, Shobo M, Inoue S, Okune M, Maeda A, Tanaka R, Kubota N, Matsumoto I, Ishii A, Tamaoka A, Shimbo A, Mori M, Morio T, Kishi T, Miyamae T, Tanboon J, Inoue M, Nishino I, Fujimoto M, Nomura T, Okiyama N. Ichimura Y, et al. Rheumatology (Oxford). 2022 Mar 2;61(3):1222-1227. doi: 10.1093/rheumatology/keab518. Rheumatology (Oxford). 2022. PMID: 34152410
224 results